Literature DB >> 34274963

Role of Age in the Spread of Influenza, 2011-2019: Data From the US Influenza Vaccine Effectiveness Network.

Eric P Griggs, Brendan Flannery, Ivo M Foppa, Manjusha Gaglani, Kempapura Murthy, Michael L Jackson, Lisa A Jackson, Edward A Belongia, Huong Q McLean, Emily T Martin, Arnold S Monto, Richard K Zimmerman, Goundappa K Balasubramani, Jessie R Chung, Manish Patel.   

Abstract

Intraseason timing of influenza infection among persons of different ages could reflect relative contributions to propagation of seasonal epidemics and has not been examined among ambulatory patients. Using data from the US Influenza Vaccine Effectiveness Network, we calculated risk ratios derived from comparing weekly numbers of influenza cases prepeak with those postpeak during the 2010-2011 through 2018-2019 influenza seasons. We sought to determine age-specific differences during the ascent versus descent of an influenza season by influenza virus type and subtype. We estimated 95% credible intervals around the risk ratios using Bayesian joint posterior sampling of weekly cases. Our population consisted of ambulatory patients with laboratory-confirmed influenza who enrolled in an influenza vaccine effectiveness study at 5 US sites during 9 influenza seasons after the 2009 influenza A virus subtype H1N1 (H1N1) pandemic. We observed that young children aged <5 years tended to more often be infected with H1N1 during the prepeak period, while adults aged ≥65 years tended to more often be infected with H1N1 during the postpeak period. However, for influenza A virus subtype H3N2, children aged <5 years were more often infected during the postpeak period. These results may reflect a contribution of different age groups to seasonal spread, which may differ by influenza virus type and subtype. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2021. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  age distribution; disease transmission, infectious; epidemics; influenza, human; outpatients

Mesh:

Substances:

Year:  2022        PMID: 34274963      PMCID: PMC9004732          DOI: 10.1093/aje/kwab205

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   5.363


  21 in total

1.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.

Authors:  Suzanne E Ohmit; Mark G Thompson; Joshua G Petrie; Swathi N Thaker; Michael L Jackson; Edward A Belongia; Richard K Zimmerman; Manjusha Gaglani; Lois Lamerato; Sarah M Spencer; Lisa Jackson; Jennifer K Meece; Mary Patricia Nowalk; Juhee Song; Marcus Zervos; Po-Yung Cheng; Charles R Rinaldo; Lydia Clipper; David K Shay; Pedro Piedra; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2013-11-13       Impact factor: 9.079

2.  Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting.

Authors:  Katelyn M Gostic; Monique Ambrose; Michael Worobey; James O Lloyd-Smith
Journal:  Science       Date:  2016-11-11       Impact factor: 47.728

3.  On the relative role of different age groups in influenza epidemics.

Authors:  Colin J Worby; Sandra S Chaves; Jacco Wallinga; Marc Lipsitch; Lyn Finelli; Edward Goldstein
Journal:  Epidemics       Date:  2015-12       Impact factor: 4.396

4.  Optimizing infectious disease interventions during an emerging epidemic.

Authors:  Jacco Wallinga; Michiel van Boven; Marc Lipsitch
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

5.  Age-specific differences in influenza A epidemic curves: do children drive the spread of influenza epidemics?

Authors:  Dena Schanzer; Julie Vachon; Louise Pelletier
Journal:  Am J Epidemiol       Date:  2011-05-20       Impact factor: 4.897

6.  Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness.

Authors:  Melissa A Rolfes; Ivo M Foppa; Shikha Garg; Brendan Flannery; Lynnette Brammer; James A Singleton; Erin Burns; Daniel Jernigan; Sonja J Olsen; Joseph Bresee; Carrie Reed
Journal:  Influenza Other Respir Viruses       Date:  2018-02-14       Impact factor: 4.380

7.  Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility.

Authors:  Sigrid Gouma; Kangchon Kim; Madison E Weirick; Megan E Gumina; Angela Branche; David J Topham; Emily T Martin; Arnold S Monto; Sarah Cobey; Scott E Hensley
Journal:  Nat Commun       Date:  2020-09-11       Impact factor: 17.694

8.  Earliest infections predict the age distribution of seasonal influenza A cases.

Authors:  Philip Arevalo; Huong Q McLean; Edward A Belongia; Sarah Cobey
Journal:  Elife       Date:  2020-07-07       Impact factor: 8.140

9.  Influenza Vaccine Effectiveness: Defining the H3N2 Problem.

Authors:  Edward A Belongia; Huong Q McLean
Journal:  Clin Infect Dis       Date:  2019-10-30       Impact factor: 9.079

10.  Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.

Authors:  Danuta M Skowronski; Catharine Chambers; Suzana Sabaiduc; Gaston De Serres; Anne-Luise Winter; James A Dickinson; Jonathan B Gubbay; Steven J Drews; Christine Martineau; Hugues Charest; Mel Krajden; Nathalie Bastien; Yan Li
Journal:  J Infect Dis       Date:  2017-12-19       Impact factor: 5.226

View more
  1 in total

1.  Surveying Parents' Awareness and Adherence to Influenza Vaccination Recommendations in Children in Southern Italy.

Authors:  Gabriella Di Giuseppe; Giovanna Paduano; Sara Vaienna; Giuseppe Maisto; Concetta Paola Pelullo; Maria Pavia
Journal:  Vaccines (Basel)       Date:  2022-08-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.